<DOC>
	<DOCNO>NCT01744106</DOCNO>
	<brief_summary>This study design confirm effectiveness single-ingredient pseudoephedrine child temporary relief nasal congestion due common cold , indication describe 21 CFR 341.80 ( b ) ( 1 ) .</brief_summary>
	<brief_title>A Multicenter Study Pseudoephedrine Temporary Relief Nasal Congestion Children With Common Cold</brief_title>
	<detailed_description />
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Pseudoephedrine</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<criteria>1 . Male female subject , age 6 11 year , experience common cold , otherwise healthy . 2 . Subjects onset cold symptom within past 2.5 day screen experience selfreported nasal congestion least stuffy severity ( score = 3 4 ) . 3 . Subjects least two follow additional symptom due common cold : runny nose , sneeze , sore throat , headache , body achiness , cough , deem parent . 4 . Subjects swallow oral tablet without chew ( base pretest successfully swallow placebo tablet screen ) 5 . Findings medical history review vital sign within range clinical acceptability , determine investigator . 6 . Subject legally authorize representative likely compliant complete study . 7 . Subject 's legally authorize representative sign date informed consent form . Subject give verbal assent , sign date informed assent form . 8 . Female subject reach menarche must negative urine pregnancy test screening . These subject must practice abstinence least three month prior study entry duration study . A second pregnancy test give subject return clinic last dose . 9 . Subject legally authorized representative read understand English . 10 . Subject 's legally authorize representative sign inform consent available administer assessment study medication day 1 2 . 1 . Have follow medical condition : heart disease , high blood pressure , thyroid disease , diabetes , peripheral vascular disease , increase intraocular pressure , prostatic hypertrophy 2 . Are treatment hyperexcitability disorder medication regimen stable least 3 month 3 . Are currently experience asthmatic episode 4 . Are experience symptom seasonal perennial allergic rhinitis 5 . Are currently within last 24 hour symptom vomit diarrhea 6 . Have expose immediate family member flu within past week 7 . Are exhibit sign symptom , diagnose sinusitis , pneumonia , strep throat , acute otitis medium , influenza 8 . Are experience fever 103ËšF high screening 9 . Are home smoke home around child . 10 . Are currently take monoamine oxidase inhibitor ( MAOI ) , take MAOI within two week screen ( e.g. , isocarboxazid Marplan , phenelzine Nardil , selegiline Eldepryl , Emsam , Zelapar , tranylcypromine Parnate ) . Note : subject may discontinue take MAOI solely purpose qualify study . 11 . Have know sensitivity allergy pseudoephedrine , phenylephrine , acetaminophen excipients drug product 12 . Have take oral cold allergy medicine within 12 hour enrollment , intranasal decongestant within 24 hour enrollment except singleingredient OTC analgesic 13 . Have need take additional medication , include cough cold ( i.e. , oral intranasal antihistamine , intranasal steroid , intranasal decongestant ) , herbal/dietary supplement study , exception acetaminophen , medication regimen hyperexcitability disorder stable least three month daily vitamin multivitamin/multimineral supplement 14 . Have participate another clinical study within 30 day entry 15 . Have another child household currently participate study 16 . Have history drug , alcohol , tobacco use ( old child ) 17 . Are involve directly indirectly conduct administration study ( i.e. , child principal investigator , subinvestigator , study coordinator , study personnel , employee Perrigo , family ) .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>